Skip to main content
Top
Published in: Neuroscience Bulletin 6/2016

01-12-2016 | Report

Olfactory Dysfunction in Parkinson’s Disease Patients with the LRRK2 G2385R Variant

Authors: Ming Cao, Zhu-Qin Gu, Yuan Li, Hui Zhang, Xiao-Juan Dan, Shan-Shan Cen, Da-Wei Li, Piu Chan

Published in: Neuroscience Bulletin | Issue 6/2016

Login to get access

Abstract

Olfactory dysfunction has been reported in Parkinson’s disease (PD) patients carrying the LRRK2 G2019S variant in Caucasians but rarely in those with the LRRK2 G2385R variant. In this study, we performed genotyping for the LRRK2 G2385R variant in PD patients recruited from the Movement Disorder Clinic of Xuanwu Hospital in Beijing and in healthy controls randomly selected from the Beijing Longitudinal Study on Aging cohort. The “five-odor olfactory detection array”, an olfactory threshold test, was used to assess olfactory function. One hundred and eighty-six participants were enrolled, comprising 43 PD patients without (iPD) and 25 with (LRRK2-PD) the LRRK2 G2385R variant, and 118 healthy controls. Our results showed that the threshold of olfactory identification was significantly worse in PD patients than in controls, but not significantly different between the iPD and LRRK2-PD groups. These findings suggested that although olfactory function in LRRK2-PD patients is impaired, it is similar to that in iPD patients.
Literature
1.
go back to reference Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988, 38: 1237–1244.CrossRefPubMed Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988, 38: 1237–1244.CrossRefPubMed
2.
go back to reference Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, et al. Prevalence of smell loss in Parkinson’s disease–a multicenter study. Parkinsonism Relat Disord 2009, 15: 490–494.CrossRefPubMed Haehner A, Boesveldt S, Berendse HW, Mackay-Sim A, Fleischmann J, Silburn PA, et al. Prevalence of smell loss in Parkinson’s disease–a multicenter study. Parkinsonism Relat Disord 2009, 15: 490–494.CrossRefPubMed
4.
go back to reference Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al. Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 2008, 63: 167–173.CrossRefPubMed Ross GW, Petrovitch H, Abbott RD, Tanner CM, Popper J, Masaki K, et al. Association of olfactory dysfunction with risk for future Parkinson’s disease. Ann Neurol 2008, 63: 167–173.CrossRefPubMed
5.
go back to reference Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol 2008, 7: 583–590.CrossRefPubMedPubMedCentral Healy DG, Falchi M, O’Sullivan SS, Bonifati V, Durr A, Bressman S, et al. Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson’s disease: a case-control study. Lancet Neurol 2008, 7: 583–590.CrossRefPubMedPubMedCentral
6.
go back to reference Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson’s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005, 128: 2786–2796.CrossRefPubMed Khan NL, Jain S, Lynch JM, Pavese N, Abou-Sleiman P, Holton JL, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson’s disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005, 128: 2786–2796.CrossRefPubMed
7.
go back to reference Ruiz-Martinez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodriguez F, et al. Olfactory deficits and cardiac 123I-MIBG in Parkinson’s disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 2011, 26: 2026–2031.CrossRefPubMed Ruiz-Martinez J, Gorostidi A, Goyenechea E, Alzualde A, Poza JJ, Rodriguez F, et al. Olfactory deficits and cardiac 123I-MIBG in Parkinson’s disease related to the LRRK2 R1441G and G2019S mutations. Mov Disord 2011, 26: 2026–2031.CrossRefPubMed
8.
go back to reference Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, et al. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 2011, 77: 319–324.CrossRefPubMedPubMedCentral Saunders-Pullman R, Stanley K, Wang C, San Luciano M, Shanker V, Hunt A, et al. Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 2011, 77: 319–324.CrossRefPubMedPubMedCentral
9.
go back to reference Wang C, Cai Y, Gu Z, Ma J, Zheng Z, Tang BS, et al. Clinical profiles of Parkinson’s disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiol Aging 2014, 35: 725 e721–726. Wang C, Cai Y, Gu Z, Ma J, Zheng Z, Tang BS, et al. Clinical profiles of Parkinson’s disease associated with common leucine-rich repeat kinase 2 and glucocerebrosidase genetic variants in Chinese individuals. Neurobiol Aging 2014, 35: 725 e721–726.
10.
go back to reference Li DW, Gu Z, Wang C, Ma J, Tang BS, Chen SD, et al. Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants. J Neural Transm (Vienna) 2015, 122: 661–667.CrossRef Li DW, Gu Z, Wang C, Ma J, Tang BS, Chen SD, et al. Non-motor symptoms in Chinese Parkinson’s disease patients with and without LRRK2 G2385R and R1628P variants. J Neural Transm (Vienna) 2015, 122: 661–667.CrossRef
11.
go back to reference Tian X, Tang Z, Jiang J, Fang X, Wu X, Han W, et al. Effects of smoking and smoking cessation on life expectancy in an elderly population in Beijing, China, 1992-2000: an 8-year follow-up study. J Epidemiol 2011, 21: 376–384.CrossRefPubMedPubMedCentral Tian X, Tang Z, Jiang J, Fang X, Wu X, Han W, et al. Effects of smoking and smoking cessation on life expectancy in an elderly population in Beijing, China, 1992-2000: an 8-year follow-up study. J Epidemiol 2011, 21: 376–384.CrossRefPubMedPubMedCentral
12.
go back to reference Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988, 51: 745–752.CrossRefPubMedPubMedCentral Gibb WR, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 1988, 51: 745–752.CrossRefPubMedPubMedCentral
13.
go back to reference Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, et al. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease. Eur Neurol 2011, 66: 98–105.CrossRefPubMed Wu X, Yu C, Fan F, Zhang K, Zhu C, Wu T, et al. Correlation between progressive changes in piriform cortex and olfactory performance in early Parkinson’s disease. Eur Neurol 2011, 66: 98–105.CrossRefPubMed
14.
go back to reference Sun AN CX, Hai XL. Development of ‘five odors olfactory detection arrays’ and olfactory threshold testing in health young people. Chin J Otorhinolaryngol 1992, 27: 35–38. Sun AN CX, Hai XL. Development of ‘five odors olfactory detection arrays’ and olfactory threshold testing in health young people. Chin J Otorhinolaryngol 1992, 27: 35–38.
15.
go back to reference Su M, Wang S, Fang W, Zhu Y, Li R, Sheng K, et al. Alterations in the limbic/paralimbic cortices of Parkinson’s disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis. Parkinsonism Relat Disord 2015, 21: 698–703.CrossRefPubMed Su M, Wang S, Fang W, Zhu Y, Li R, Sheng K, et al. Alterations in the limbic/paralimbic cortices of Parkinson’s disease patients with hyposmia under resting-state functional MRI by regional homogeneity and functional connectivity analysis. Parkinsonism Relat Disord 2015, 21: 698–703.CrossRefPubMed
16.
go back to reference Zhang LiYan CP. Olfactory function in patients with Parkinson’s disease. Chin J Neurol 2004, 37: 529–532. Zhang LiYan CP. Olfactory function in patients with Parkinson’s disease. Chin J Neurol 2004, 37: 529–532.
17.
go back to reference Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson’s disease in Asia. Parkinsonism Relat Disord 2007, 13: 89–92.CrossRefPubMed Farrer MJ, Stone JT, Lin CH, Dachsel JC, Hulihan MM, Haugarvoll K, et al. Lrrk2 G2385R is an ancestral risk factor for Parkinson’s disease in Asia. Parkinsonism Relat Disord 2007, 13: 89–92.CrossRefPubMed
18.
go back to reference Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004, 19: 1020–1028.CrossRefPubMed Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004, 19: 1020–1028.CrossRefPubMed
19.
go back to reference Doty RL. Influence of age and age-related diseases on olfactory function. Ann N Y Acad Sci 1989, 561: 76–86.CrossRefPubMed Doty RL. Influence of age and age-related diseases on olfactory function. Ann N Y Acad Sci 1989, 561: 76–86.CrossRefPubMed
20.
go back to reference Vilas D, Ispierto L, Alvarez R, Pont-Sunyer C, Marti MJ, Valldeoriola F, et al. Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Parkinsonism Relat Disord 2015, 21: 1170–1176.CrossRefPubMed Vilas D, Ispierto L, Alvarez R, Pont-Sunyer C, Marti MJ, Valldeoriola F, et al. Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers. Parkinsonism Relat Disord 2015, 21: 1170–1176.CrossRefPubMed
21.
go back to reference Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, et al. Fall risk and gait in Parkinson’s disease: the role of the LRRK2 G2019S mutation. Mov Disord 2013, 28: 1683–1690.CrossRefPubMed Mirelman A, Heman T, Yasinovsky K, Thaler A, Gurevich T, Marder K, et al. Fall risk and gait in Parkinson’s disease: the role of the LRRK2 G2019S mutation. Mov Disord 2013, 28: 1683–1690.CrossRefPubMed
22.
go back to reference Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol 2007, 254: 84–90.CrossRefPubMed Bohnen NI, Gedela S, Kuwabara H, Constantine GM, Mathis CA, Studenski SA, et al. Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson’s disease. J Neurol 2007, 254: 84–90.CrossRefPubMed
23.
24.
go back to reference Daum RF, Sekinger B, Kobal G, Lang CJ. Olfactory testing with “sniffin’ sticks” for clinical diagnosis of Parkinson disease. Nervenarzt 2000, 71: 643–650.CrossRefPubMed Daum RF, Sekinger B, Kobal G, Lang CJ. Olfactory testing with “sniffin’ sticks” for clinical diagnosis of Parkinson disease. Nervenarzt 2000, 71: 643–650.CrossRefPubMed
25.
go back to reference Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003, 60: 545–549.CrossRefPubMed Double KL, Rowe DB, Hayes M, Chan DK, Blackie J, Corbett A, et al. Identifying the pattern of olfactory deficits in Parkinson disease using the brief smell identification test. Arch Neurol 2003, 60: 545–549.CrossRefPubMed
26.
go back to reference Fu X, Zheng Y, Hong H, He Y, Zhou S, Guo C, et al. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson’s disease in a Han Chinese population from Southern Mainland China. Parkinsonism Relat Disord 2013, 19: 397–398.CrossRefPubMed Fu X, Zheng Y, Hong H, He Y, Zhou S, Guo C, et al. LRRK2 G2385R and LRRK2 R1628P increase risk of Parkinson’s disease in a Han Chinese population from Southern Mainland China. Parkinsonism Relat Disord 2013, 19: 397–398.CrossRefPubMed
27.
go back to reference Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 1995, 10: 283–287.CrossRefPubMed Pearce RK, Hawkes CH, Daniel SE. The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 1995, 10: 283–287.CrossRefPubMed
28.
go back to reference Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology. Lancet 1992, 340: 186.CrossRefPubMed Daniel SE, Hawkes CH. Preliminary diagnosis of Parkinson’s disease by olfactory bulb pathology. Lancet 1992, 340: 186.CrossRefPubMed
29.
go back to reference Hawkes CH, Shephard BC, Daniel SE. Is Parkinson’s disease a primary olfactory disorder? QJM 1999, 92: 473–480.CrossRefPubMed Hawkes CH, Shephard BC, Daniel SE. Is Parkinson’s disease a primary olfactory disorder? QJM 1999, 92: 473–480.CrossRefPubMed
30.
go back to reference Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 2015, 72: 100–105.CrossRefPubMedPubMedCentral Kalia LV, Lang AE, Hazrati LN, Fujioka S, Wszolek ZK, Dickson DW, et al. Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 2015, 72: 100–105.CrossRefPubMedPubMedCentral
31.
go back to reference Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 2008, 71: 1021–1026.CrossRefPubMed Silveira-Moriyama L, Guedes LC, Kingsbury A, Ayling H, Shaw K, Barbosa ER, et al. Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data. Neurology 2008, 71: 1021–1026.CrossRefPubMed
Metadata
Title
Olfactory Dysfunction in Parkinson’s Disease Patients with the LRRK2 G2385R Variant
Authors
Ming Cao
Zhu-Qin Gu
Yuan Li
Hui Zhang
Xiao-Juan Dan
Shan-Shan Cen
Da-Wei Li
Piu Chan
Publication date
01-12-2016
Publisher
Springer Singapore
Published in
Neuroscience Bulletin / Issue 6/2016
Print ISSN: 1673-7067
Electronic ISSN: 1995-8218
DOI
https://doi.org/10.1007/s12264-016-0070-5

Other articles of this Issue 6/2016

Neuroscience Bulletin 6/2016 Go to the issue